Results 151 to 160 of about 883,694 (328)
Management of cardiogenic shock. [PDF]
EuroIntervention, 2021 Thiele H +5 more
europepmc +1 more source
Direct measurement of the cross-shock electric potential at low plasma $β$, quasi-perpendicular bow shocks [PDF]
arXiv, 2008 We use the Cluster EFW experiment to measure the cross-shock electric field at ten low $\beta$, quasi-perpendicular supercritical bow shock crossings on March 31, 2001. The electric field data are Lorentz-tranformed to a Normal Incidence frame (NIF), in which the incoming solar wind velocity is aligned with the shock normal.
arxiv
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
ESC Heart Failure, EarlyView.Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna +4 more
wiley +1 more source
Bioscience Journal, 2017 Cardiogenic shock is a state of systemic tissue hypoperfusion resulting from a primary cardiac dysfunction. When it occurs simultaneously to a non reperfusion coronary artery phenomenon, prognosis worsens and mortality chances increases.
Poliana Rodrigues Alves Duarte +4 more
doaj +3 more sources
Management of Mechanical Ventilation in Decompensated Heart Failure. [PDF]
, 2016 Mechanical ventilation (MV) is a life-saving intervention for respiratory failure, including decompensated congestive heart failure. MV can reduce ventricular preload and afterload, decrease extra-vascular lung water, and decrease the work of breathing ...
Adams, Jason Y +4 more
core +4 more sources
ESC Heart Failure, EarlyView.In the context of patients with severe heart failure, it is crucial to ensure adequate preconditioning before considering the implantation of dLVAD. Although several types of mechanical circulatory assist devices are available and all offer a significant advantage, the present study suggests that the higher the flow rate provided by the Impella®, the ...
Marta L. Medina +32 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta +10 more
wiley +1 more source
Circulating levels of microRNA 423-5p are associated with 90 day mortality in cardiogenic shock [PDF]
, 2019 Aims The role of microRNAs has not been studied in cardiogenic shock. We examined the potential role of miR-423-5p level to predict mortality and associations of miR-423-5p with prognostic markers in cardiogenic shock.
Bayes-Genis, Antoni +12 more
core +1 more source
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
ESC Heart Failure, EarlyView.This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna +18 more
wiley +1 more source
Cardiogenic shock: do not forget the possibility of Kawasaki disease
The Turkish Journal of Pediatrics, 2012 We report the case of a six-year-old boy who presented with cardiogenic shock due to Kawasaki disease (KD). He was misdiagnosed at first as septic shock.
Wei Wang +4 more
doaj